FDA Issues Draft Guidance on Exclusivity Determinations for Biological Products | Practical Law
The US Food and Drug Administration (FDA) issued draft industry guidance for biologics developers and other interested parties explaining how it will determine the date of first licensure for a biological product's regulatory exclusivity period.